Prostatein or steroid binding protein (PSBP) induces experimental autoimmune prostatitis (EAP) in NOD mice

Clinical Immunology

Volumn 105, Issue 2, 2002, Pages 176-184

  Rivero, Virginia ^a   Carnaud, Claude ^b   Riera, Clelia Maria ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Autoimmunity; NOD mice; Prostatic antigens; Susceptibility

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTATEIN; STEROID BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXPERIMENTAL ANIMAL; INHERITANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATITIS; PROTEIN INDUCTION; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY;

EID: 0036865737     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5281     Document Type: Article

References (30)

1. McNaughton, C. M., MacDonald, R., and Wilt, T. J., Diagnosis and treatment of chronic abacterial prostatitis: A systematic review. Ann. Intern. Med. 133, 367-381, 2000.
2. Doble, A., Walker, M. M., Harris, J. R., Taylor-Robinson, D., and Whitherow, R. O., Intraprostatic antibody deposition in chronic abacterial prostatitis. Br. J. Urol. 65, 598-605, 1990.
3. Alexander, R. B., Brady, F., and Ponniah, S., Autoimmune prostatitis: Evidence of T cell reactivity with normal prostatic proteins. Urology 50, 893-899, 1997.
4. Galmarini, M., Ferro, M. E., and Riera, C. M., Delayed hypersensitivity and lesions following isoimmunization with modified rat male accessory glands: Kinetics of induction. J. Reprod. Immunol. 13, 147-157, 1988.
5. Rivero, V. E., Iribarren, P., and Riera, C. M., Mast cells in accessory glands of experimentally induced prostatitis in male Wistar rats. Clin. Immunol. Immunopathol. 74, 236-242, 1995.
6. Casas-Ingaramo, A., Depiante-Depaoli, M., and Pacheco-Rupil, B., Activation of citotoxic cells by syngenic prostate antigens in experimental autoimmune vesiculo-prostatitis. Autoimmunity 9, 151-157, 1991.
7. Orsilles, M. A., Donadio, A. C., and Depiante-Depaoli, M., Time course of reactive oxygen intermediates release and histological findings during experimental prostatitis development. Prostate 27, 50-57, 1995.
8. Bernard, N. F., Ertug, F., and Margolese, H., High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes 41, 40-46, 1992.
9. Krug, J. A., Williams, J. K., Beales, P. E., Doniach, E. A., Gale, M., and Pozzilli, P., Parathyroiditis in the non-obese diabetic mouse: A new finding. J. Endocrinol. 131, 193-196, 1991.
10. Damotte, D., Colomb, E., Cailleau, C., Brousse, N., Charreire, J., and Carnaud, C., Analysis of susceptibility of NOD mice to spontaneous and experimentally induced thyroiditis. Eur. J. Immunol. 27, 2854-2862, 1997.
11. Rivero, V. E., Cailleau, C., Depiante-Depaoli, M., Riera, C. M., and Carnaud, C., Non-obese diabetic (NOD) mice are genetically susceptible to Experimental Autoimmune Prostatitis (EAP). J. Autoimmun. 11, 603-610, 1998.
12. Maccioni, M., Donadio, A. C., Rivero, V. E., Depiante-Depaoli, M.,Carnaud, C., and Riera, C. M., Ratones NOD (non-obesediabetic) de edad avanzada desarrollan espontáneamente prostatitis autoinmune. Medicina (Bs. As.), 58, 616, 1998.
13. Liu, K. J., Chatta, G. S., Twardzik, D. R., Vedvick, T. S., True, L. D., Spies, A. G., and Cheever, M. A., Identification of rat prostatic steroid binding protein as a target antigen of experimental autoimmune prostatitis, J. Immunol. 159, 472-480, 1997.
14. Maccioni, M., Rivero, V. E., and Riera, C. M., Prostatein is a major autoantigen in experimental autoimmune prostatitis. Clin. Exp. Immunol. 112, 159-165, 1998.
15. Forsgren, B., Gustafsson, J. A., Pousette, A., and Hogberg, B., Binding characteristics of a major protein in the rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta estradiol. Cancer Res. 39, 5155-5164, 1979.
16. Forsgren, B., Bjork, P., Carlstrom, K., Gustafsson, J. A., Pousette, A., and Hogberg, B., Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of 17-beta estradiol. Proc. Natl. Acad. Sci. USA 76, 3149-3153, 1979.
17. Katz, J., Benoist, C., and Mathis, D., Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23, 3358-3350, 1993.
18. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Leumer, M., Benoist, C., and Mathis, D., Mice lacking MHC II molecules. Cell 66, 1051-1066, 1991.
19. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent. J. Biol. Chem. 198, 265-275, 1951.
20. Chen, C., Schilling, K., Hiipakka, R. A., Huang, I-Y., and Liao, S., Prostate alpha protein. Isolation and characterisation of the polipeptide components and cholesterol binding. J. Biol. Chem. 257, 116-121, 1982.
21. Galmarini, M., Serra, H. M., Pistoresi-Palencia, M. C., Vottero-Cima, E., and Riera, C. M., Production of rat male accessory gland lesions by transfer of spleen mononuclear cells. Cell Mol. Biol. 32, 293-301, 1986.
22. Bach, J. F., Koutouzov, S., and van Endert, P. M., Are there unique autoantigens triggering autoimmune diseases?. Immunol. Rev. 164, 139-155, 1998.
23. Mocci, S., Lafferty, K., and Howard, M., The role of autoantigens in autoimmune disease. Curr. Opin. Immunol. 12, 725-730, 2000.
24. Lehmann, P. V., Forsthuber, T., Miller, A., and Sercarz, E. E., Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155-157, 1992.
25. McRae, B. L., Vanderlugt, C. L., Dal Canto, M. C., and Miller, S. D., Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182, 75-85, 1995.
26. McCluskey, J., Farris, D. A., Keech, C. L., Purcell, A. W., Rischmueller, M., Kinoshita, G., Reynolds, P., and Gordon, T. P., Determinant spreading: Lessons from animal models and human diseases. Immunol. Rev. 164, 209-229, 1998.
27. Wong, F. S., and Janeway, C. A., Jr., Insulin-dependent diabetes mellitus and its animal models. Curr. Opin. Immunol. 11, 643-647, 1999.
28. Mora, C., Wong, F. S., Chang, C. H., and Flavell, R. A., Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: Studies using NOD/CIITA-deficient mice. J. Immunol. 162, 4576-4588, 1999.
29. McDevitt, H. O., The role of MHC class II molecules in susceptibility and resistence to autoimmunity. Curr. Opin. Immunol. 10, 677-681, 1998.
30. Wicker, L. S., Leiter, E. H., Todd, J. A., Renjilian, R. J., Peterson, E., Fischer, P. A., Podolin, P. L., Zijlstra, M., Jaenisch, R., and Peterson, L. B., Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43, 500-504, 1994.